AHL
AMRX icon

Abel Hall LLC’s Amneal Pharmaceuticals AMRX Stock Holding History

Abel Hall LLC’s Portfolio AMRX Stock Details AMRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$197K Buy
11,358
+828
+8% +$11.3K 0.03% 746
2026
Q1 		$131K Sell
10,530
-8,772
-45% -$118K 0.03% 671
2025
Q4 		$243K Buy
+19,302
New +$221K 0.06% 445

Other funds holding AMRX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TGA
TPG GP A Fort Worth, Texas $5B AUM 58.56% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Abel Hall LLC's AMRX Position: Q2 2026 in Review

Abel Hall LLC increased its Amneal Pharmaceuticals (AMRX) stake by 7.9% in Q2 2026, buying an estimated $11.3K and bringing the position to 11,358 shares worth $197K. The position accounts for 0.03% of the portfolio, ranked #746.

Abel Hall LLC first reported a position in AMRX in Q4 2025 and has held it in 3 quarters since. The position peaked at $243K in Q4 2025. 310 funds tracked by Wall St. Rank hold AMRX as of Q2 2026.

  • Abel Hall LLC held 11,358 shares of Amneal Pharmaceuticals worth $197K as of Q2 2026.
  • Abel Hall LLC bought 828 Amneal Pharmaceuticals shares in Q2 2026, an estimated $11.3K.
  • Amneal Pharmaceuticals made up 0.03% of Abel Hall LLC's portfolio in Q2 2026, its #746 holding.
  • Abel Hall LLC first reported a position in Amneal Pharmaceuticals in Q4 2025 and has held it in 3 quarters since.
  • Abel Hall LLC's Amneal Pharmaceuticals position peaked at $243K in Q4 2025.
  • 310 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q2 2026.

Based on Abel Hall LLC's 13F filing for Q2 2026, filed 24 Jul 2026.